Clinical Trial Update: Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing aripiprazole and olanzapine for acute schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)
• Zyprexa (olanzapine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED